CEO Rich Gelfond is forecasting a $1.2 billion year for the company, which would be a record for the 55-year-old business.

The theater format is quickly gaining market share as moviegoers spend more to see blockbusters like "F1," "Sinners" and ...

Despite healthcare spending cuts, medtech stocks like Edwards Life Sciences, Stryker, and Boston Scientific are rising, ...